MUC1 and pancreatic neoplasm: In addition, MUC1 can increase the carbon flux of the non-oxidative pentose phosphate pathway (PPP) and pyrimidine synthesis pathway of pancreatic cancer cells by promoting the expression of HIF-1α, leading to gemcitabine resistance [34].